| Description | This product is a recombinant Human antibody provided by CreativeBiolabs. The antibody is specific for C-C motif chemokine ligand 17. It can be used for C-C motif chemokine ligand 17 detection in Enzyme-Linked Immunosorbent Assay. It was expressed in mammalian cells (293F or CHO) with antibody encoding genes and purified by affinity chromatography. Each lot of this antibody is quality control tested by SDS-PAGE and SEC-HPLC analysis. For highly sensitive assays, we recommend the ultrapurified form of the product, which has a lower endotoxin limit than standard antibody, less than 1 EU/mg or even 0.1 EU/mg. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human, Cynomolgus |
| Immunogen | Biotinylated human CCL17 |
| Affinity | The affinity is in picomolar range, about 39 pM, determined by surface plasmon resonance. |
| Isotype | IgG |
| Expression Species | HEK293F or CHO Cell line |
| Conjugation | Unconjugated, also available for Biotin, HRP, FITC and PE-labeled form. |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Purified with Protein A or G affinity chromatography |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | CCL17 |
| Alternative Name | C-C Motif Chemokine Ligand 17; Chemokine (C-C Motif) Ligand 17; Small Inducible Cytokine Subfamily A (Cys-Cys), Member 17; Thymus And Activation-Regulated Chemokine; Small-Inducible Cytokine A17; CC Chemokine TARC; SCYA17; TARC; T Cell-Directed CC Chemokine; A-152E5.3; ABCD-2 |
| Gene ID | 6361 |
| UniProt | Q92583 |
| Research Area | Immunology |
| Related Disease | Ulcerative colitis (UC), atopic dermatitis (AD), idiopathic pulmonary fibrosis (IPF) and asthma |
